Natural Acquired Immunity Against <i>Haemophilus influenzae</i> Type-B in Patients Undergoing Hemodialysis Jahrom, Iran, 2022
| Author | Masihollah Shakeri | en |
| Author | Vahid Rahmanian | en |
| Author | Farhang Hooshmand | en |
| Author | Naghmeh Bina | en |
| Author | Abdolreza Sotoodeh Jahromi | en |
| Orcid | Masihollah Shakeri [0000-0001-9184-9912] | en |
| Orcid | Vahid Rahmanian [0000-0003-3460-7495] | en |
| Orcid | Farhang Hooshmand [0000-0002-6605-5464] | en |
| Orcid | Abdolreza Sotoodeh Jahromi [0000-0002-2131-2113] | en |
| Issued Date | 2022-11-30 | en |
| Abstract | Background: End stage renal disease (ESRD) patients who undergo hemodialysis treatment suffer from immune system disorders. The immunodeficiency of these patients makes them prone to various infections. Objectives: To investigate the prevalence of naturally acquired immunity against Haemophilus influenzae type-B (Hib) and its association with the duration of dialysis treatment, gender, and age of patients in hemodialysis patients in Jahrom city, Iran. Methods: This cross-sectional descriptive was conducted on ESRD patients undergoing hemodialysis treatment, referred to Jahrom Hemodialysis Center, June - August,2022. In order to determine the presence or absence of an immunity to Hib in the patients, the qualitative level of anti-Hib Polyribosyl-ribitol-phosphate (anti-Hib PRP) antibodies in the serum of the patients were determined using the ELISA test using a specialized commercial kit. SPSS-21 was used to analyze the data. The chi-square test, univariate and multivariable logistic regression were used for data analysis. Results: The prevalence of naturally acquired immunity to Hib in patients was 26.13% (10.22% short-term immunity, 15.91% long-term immunity). A significant relationship was found between the prevalence of long-term immunity to Hib in patients and the number of dialysis sessions three times and more per week (P < 0.001). Conclusions: Considering that hemodialysis patients in Iran are not vaccinated against Hib, 26.13% prevalence of natural immunity against Hib indicates the same prevalence of Hib infection history in hemodialysis patients. A case-control study with a large sample size on hemodialysis patients is recommended to accurately determine the prevalence of Hib and to decide whether to implement a Hib vaccination program in these patients. | en |
| DOI | https://doi.org/10.5812/tms-132249 | en |
| Keyword | Natural Acquired Immunity | en |
| Keyword | <i>Haemophilus influenzae</i> Type-B (Hib) | en |
| Keyword | Hemodialysis Patients | en |
| Keyword | Iran | en |
| Publisher | Brieflands | en |
| Title | Natural Acquired Immunity Against <i>Haemophilus influenzae</i> Type-B in Patients Undergoing Hemodialysis Jahrom, Iran, 2022 | en |
| Type | Research Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- tms-2-4-132249.pdf
- Size:
- 140.18 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF